Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

iSpecimen (ISPC) Liabilities and Shareholders Equity (2020 - 2025)

Historic Liabilities and Shareholders Equity for iSpecimen (ISPC) over the last 6 years, with Q3 2025 value amounting to $9.0 million.

  • iSpecimen's Liabilities and Shareholders Equity fell 2012.27% to $9.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $31.2 million, marking a year-over-year decrease of 3936.68%. This contributed to the annual value of $9.4 million for FY2024, which is 4089.29% down from last year.
  • As of Q3 2025, iSpecimen's Liabilities and Shareholders Equity stood at $9.0 million, which was down 2012.27% from $6.0 million recorded in Q2 2025.
  • Over the past 5 years, iSpecimen's Liabilities and Shareholders Equity peaked at $35.7 million during Q4 2021, and registered a low of $6.0 million during Q2 2025.
  • Moreover, its 5-year median value for Liabilities and Shareholders Equity was $16.9 million (2023), whereas its average is $18.2 million.
  • As far as peak fluctuations go, iSpecimen's Liabilities and Shareholders Equity surged by 47522.3% in 2021, and later crashed by 4929.78% in 2025.
  • Quarter analysis of 5 years shows iSpecimen's Liabilities and Shareholders Equity stood at $35.7 million in 2021, then tumbled by 31.08% to $24.6 million in 2022, then plummeted by 35.74% to $15.8 million in 2023, then plummeted by 40.89% to $9.4 million in 2024, then decreased by 3.77% to $9.0 million in 2025.
  • Its last three reported values are $9.0 million in Q3 2025, $6.0 million for Q2 2025, and $6.8 million during Q1 2025.